mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-07 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-06 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.21 |
6e-06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-06 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
8e-06 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
2e-05 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |